Get the Stockscreener App
115.43
0.16%
-0.18
After Hours:
115.18
-0.25
-0.22%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $115.43, with a volume of 8.78M.
It is down -0.16% in the last 24 hours and down -4.93% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$115.61
Open:
$115.34
24h Volume:
8.78M
Relative Volume:
0.69
Market Cap:
$285.39B
Revenue:
$64.93B
Net Income/Loss:
$18.26B
P/E Ratio:
15.87
EPS:
7.2751
Net Cash Flow:
$12.36B
1W Performance:
-1.43%
1M Performance:
-4.93%
6M Performance:
+42.35%
1Y Performance:
+22.06%
1-Day Range:
$114.22
$116.06
1-Week Range:
$114.22
$119.00
52-Week Range:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
115.43 | 285.83B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
LLY
Lilly Eli Co
|
989.12 | 879.67B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.19 | 582.04B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
221.45 | 388.43B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
192.01 | 294.50B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
154.87 | 292.79B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-20-26 | Initiated | Barclays | Overweight |
| Feb-13-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co. Inc. (NYSE:MRK) Offers a Steady Dividend Backed by Strong Fundamentals - ChartMill
Here’s Why Merck (MRK) Surged in Q4 - Insider Monkey
Merck & Co., Inc. $MRK Shares Purchased by Hamilton Wealth LLC - MarketBeat
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics - GlobeNewswire Inc.
Gotham Asset Management LLC Acquires 113,226 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fayez Sarofim & Co Has $201.96 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Wealth Buys 22,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Stock (ISIN: US58933Y1055) Hits Dividend Date as Analysts Raise Targets on Oncolog - AD HOC NEWS
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? - Insider Monkey
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss - Insider Monkey
Elevation Point Wealth Partners LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Crawford Investment Counsel Inc. Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Brevan Howard Capital Management LP Sells 355,802 Shares of Merck & Co., Inc. $MRK - MarketBeat
Circle Wealth Management LLC Has $13.62 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Cinctive Capital Management LP Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by California Public Employees Retirement System - MarketBeat
Bank of Nova Scotia Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Aquatic Capital Management LLC - MarketBeat
Aristotle Capital Management LLC Sells 317,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ameriprise Financial Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Arrow Capital Pty Ltd Invests $3.36 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Lessened by Alliancebernstein L.P. - MarketBeat
Wellington Management Group LLP Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Zuckerman Investment Group LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by M&T Bank Corp - MarketBeat
Ossiam Has $12.56 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
iSAM Funds UK Ltd Invests $4.88 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Prudential PLC - MarketBeat
Pinnbrook Capital Management LP Purchases New Holdings in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Comerica Bank Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Capital Wealth Planning LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Glenmede Investment Management LP Has $45.31 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Benchmark Investment Advisors LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat
How Merck (NYSE:MRK) Solidifies Its Financial Strength In The S&P 500 Index? - Kalkine Media
Merck & Co., Inc. Target of Unusually High Options Trading (NYSE:MRK) - MarketBeat
Tocqueville Asset Management L.P. Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat
Invesco Ltd. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Martingale Asset Management L P Sells 29,300 Shares of Merck & Co., Inc. $MRK - MarketBeat
Entropy Technologies LP Boosts Position in Merck & Co., Inc. $MRK - MarketBeat
Certuity LLC Has $2.28 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK is Arrowstreet Capital Limited Partnership's 10th Largest Position - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by American Investment Services Inc. - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
MRK SEC FilingsMerck & Co 10-K, 10-Q, 8-K Forms - Stock Titan
Merck (MRK) EVP Brian Foard submits initial insider Form 3 - Stock Titan
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150 - 24/7 Wall St.
Wells Fargo & Company Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Wells Fargo Adjusts Price Target on Merck & Co. to $150 From $135, Maintains Overweight Rating - marketscreener.com
Douglass Winthrop Advisors LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):